Search - tctmd.com

Displaying 21 - 40 of 193

Sort: Relevancy | Date

Presentation ESC 2024

The EARTH-STEMI IPD meta-analysis

Presenter: Gianluca Campo

September 01, 2024

News Conference News ESC 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Michael O'Riordan

September 06, 2023

News Daily News ESC 2023

Dietary Nitrate Dramatically Cuts Contrast-Induced Nephropathy: NITRATE-CIN

Michael O'Riordan

August 30, 2023

Presentation ESC 2023

Functional versus Culprit only Revascularization in Elderly Patients with Myocardial Infarction and Multivessel Disease

Presenter: Simone Biscaglia

August 28, 2023

Presentation ESC 2023

Extracorporeal life support for acute myocardial infarction complicated by cardiogenic shock: ECLS-SHOCK

Presenter: Holger Thiele

August 28, 2023

Presentation ESC 2023

ARREST Trial: Expedited Transfer to a Cardiac Arrest Centre for non-ST Elevation OHCA

Presenter: Tiffany Patterson

August 28, 2023

News Conference News ESC 2023

STOPDAPT-3: Don’t Skip Out on Aspirin Immediately After PCI

Todd Neale

August 26, 2023

News Conference News ESC 2023

Routine ECMO in AMICS Patients Not Protective: ECLS-SHOCK

Caitlin E. Cox

August 26, 2023

News Conference News ESC 2023

FIRE: Complete Revascularization Best Even for Elderly Patients With MI

Michael O'Riordan

August 26, 2023

News Conference News ESC 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

Michael O'Riordan

September 07, 2022

News Conference News ESC 2022

GRACE 3.0: Women With NSTE ACS Get a Boost From Updated Score

Caitlin E. Cox

September 06, 2022

News Conference News ESC 2022

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

Michael O'Riordan

August 31, 2022

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

L.A. McKeown

August 30, 2022

News Conference News ESC 2022

Less Death, Major Bleeding With Transradial Access: Meta-analysis

Michael O'Riordan

August 29, 2022

News Conference News ESC 2022

P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER

Todd Neale

August 29, 2022

Presentation ESC 2022

FFR vs. Angiography-guided PCI in AMI with multivessel disease

Presenter: Joo-Yong Hahn

August 29, 2022

Presentation ESC 2022

Efficacy and Safety of the Oral Factor XIa Inhibitor, Asundexian, Added to Dual Antiplatelet Therapy After an Acute Myocardial Infarction

Presenter: John H. Alexander

August 28, 2022

Presentation ESC 2022

Coronary Atherosclerotic Plaque Activity and Future Coronary Events

Presenter: David Newby

August 28, 2022

News Conference News ESC 2022

‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR

Shelley Wood

August 28, 2022

News Conference News ESC 2022

Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke

Todd Neale

August 28, 2022

Advertisement

The EARTH-STEMI IPD meta-analysis

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Dietary Nitrate Dramatically Cuts Contrast-Induced Nephropathy: NITRATE-CIN

Functional versus Culprit only Revascularization in Elderly Patients with Myocardial Infarction and Multivessel Disease

Extracorporeal life support for acute myocardial infarction complicated by cardiogenic shock: ECLS-SHOCK

ARREST Trial: Expedited Transfer to a Cardiac Arrest Centre for non-ST Elevation OHCA

STOPDAPT-3: Don’t Skip Out on Aspirin Immediately After PCI

Routine ECMO in AMICS Patients Not Protective: ECLS-SHOCK

FIRE: Complete Revascularization Best Even for Elderly Patients With MI

CV Care Around Noncardiac Surgery: New ESC Guidelines

GRACE 3.0: Women With NSTE ACS Get a Boost From Updated Score

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

Less Death, Major Bleeding With Transradial Access: Meta-analysis

P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER

FFR vs. Angiography-guided PCI in AMI with multivessel disease

Efficacy and Safety of the Oral Factor XIa Inhibitor, Asundexian, Added to Dual Antiplatelet Therapy After an Acute Myocardial Infarction

Coronary Atherosclerotic Plaque Activity and Future Coronary Events

‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR

Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content